Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : EBS save search
Soligenix Announces Recent Accomplishments And Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 13:00) - prnewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 4.98%
H: 14.08%
C: 11.19%
SNGX | $0.393 -1.75% 300K
|
Health Technology
|
| O: 1.67%
H: 2.21%
C: -1.47%
financial results
Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
Published: 2022-11-03 (Crawled : 13:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -2.29%
H: 1.53%
C: -0.46%
CMRX | $0.9033 -2.38% 70K
|
Health Technology
|
| O: 7.53%
H: 0.0%
C: -9.5%
financial update results
Emergent BioSolutions Presents Data from Phase 2 Study Evaluating Safety and Immunogenicity of Chikungunya Vaccine Candidate in Prior Recipients of Other Alphavirus Vaccines
Published: 2022-11-01 (Crawled : 23:00) - biospace.com/
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 1.87%
H: 1.46%
C: -1.55%
candidate vaccine study chikungunya
SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions
Published: 2022-10-27 (Crawled : 13:20) - biospace.com/
SABS | $4.36 110
|
|
| O: 7.56%
H: 4.71%
C: -1.14%
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 1.22%
H: 0.74%
C: -2.89%
partnership
Kamada Awarded $22 Million Extension of Canadian Supply Tender
Published: 2022-10-19 (Crawled : 11:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -1.07%
H: 1.14%
C: -4.04%
KMDA | $5.1 7.6K
|
Health Technology
|
| O: -1.52%
H: 3.31%
C: -0.44%
extension
Emergent BioSolutions to Release Third Quarter 2022 Financial Results and Conduct Conference Call on November 8, 2022
Published: 2022-10-18 (Crawled : 11:00) - biospace.com/
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 2.29%
H: 1.17%
C: -4.91%
conference financial results
Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
Published: 2022-09-26 (Crawled : 21:00) - biospace.com/
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -0.29%
H: 2.98%
C: -3.41%
tembexa acquisition smallpox antiviral
Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
Published: 2022-09-06 (Crawled : 11:00) - biospace.com/
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -2.58%
candidate vaccine virus study phase 1
Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox
Published: 2022-08-29 (Crawled : 15:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -2.07%
H: 2.67%
C: -1.91%
CMRX | $0.9033 -2.38% 70K
|
Health Technology
|
| O: -0.93%
H: 25.23%
C: 8.88%
smallpox tembexa contract
Soligenix Announces Recent Accomplishments And Second Quarter 2022 Financial Results
Published: 2022-08-12 (Crawled : 12:00) - prnewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 1.87%
H: 1.38%
C: 0.16%
SNGX | $0.393 -1.75% 300K
|
Health Technology
|
| O: -1.15%
H: 4.65%
C: 2.93%
results
Emergent BioSolutions to Participate in Investor Conferences - Aug 10, 2022
Published: 2022-08-10 (Crawled : 11:00) - biospace.com/
MS | News 0 d | $93.38 -0.41% 1.8M
|
Finance
|
| O: 1.35%
H: 2.43%
C: 1.55%
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 2.56%
H: 0.39%
C: 0.07%
Emergent BioSolutions to Participate in Investor Conferences
Published: 2022-08-10 (Crawled : 11:00) - globenewswire.com
MS | News 0 d | $93.38 -0.41% 1.8M
|
Finance
|
| O: 1.35%
H: 2.43%
C: 1.55%
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 2.56%
H: 0.39%
C: 0.07%
Emergent BioSolutions Reports Financial Results for Second Quarter 2022
Published: 2022-08-01 (Crawled : 22:00) - biospace.com/
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -0.09%
H: 1.88%
C: -1.1%
Emergent BioSolutions to Release Second Quarter 2022 Financial Results and Conduct Conference Call on August 1, 2022
Published: 2022-07-18 (Crawled : 00:00) - biospace.com/
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 1.18%
H: 2.4%
C: -2.36%
conference results
Kamada Announces $11.4 Million International VARIZIG® Procurement Agreement
Published: 2022-07-06 (Crawled : 11:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 5.33%
H: 1.3%
C: -0.82%
KMDA | $5.1 7.6K
|
Health Technology
|
| O: 0.0%
H: 3.52%
C: 2.86%
varizig agreement international
Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada
Published: 2022-06-24 (Crawled : 14:20) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 6.55%
H: 0.91%
C: -0.27%
CMRX | $0.9033 -2.38% 70K
|
Health Technology
|
| O: 2.2%
H: 32.8%
C: 10.75%
tembexa canada health agreement
Emergent BioSolutions Announces FDA Acceptance of Biologics License Application for AV7909 Anthrax Vaccine Candidate
Published: 2022-06-24 (Crawled : 11:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 6.55%
H: 0.91%
C: -0.27%
av7909 fda candidate vaccine application license
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
Published: 2022-06-23 (Crawled : 13:20) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 2.19%
H: 0.0%
C: 0.0%
CMRX | $0.9033 -2.38% 70K
|
Health Technology
|
| O: 1.23%
H: 10.98%
C: 10.98%
tembexa agreement international
Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenicity Data in The Lancet Infectious Diseases
Published: 2022-06-21 (Crawled : 11:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: 5.29%
H: 0.0%
C: 0.0%
lancet publication chikungunya disease phase 2
Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
Published: 2022-05-16 (Crawled : 11:00) - globenewswire.com
EBS | News | $2.185 -4.59% 480K
|
Health Technology
|
| O: -2.17%
H: 2.19%
C: -0.73%
CMRX | $0.9033 -2.38% 70K
|
Health Technology
|
| O: -53.48%
H: 2.58%
C: -14.43%
tembexa smallpox antiviral
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.